The approval was based on results from the TROPION-Breast01 Phase III trial.

Trenchant BioSystems Inc., a CGT manufacturing platform developer for gene-modified cells, and Autolomous, a cloud-based, ...

Cormica, an expert in life sciences testing and consulting, has acquired Zwisler Laboratorium, a provider of laboratory ...

Kincell Bio, a cell therapy development and manufacturing organization (CDMO), has appointed Mark R. Bamforth as Chief Executive Officer (CEO), effective immediately.

Aims to enhance RNA production technologies with the goal of a continuous manufacturing platform and advancement of PAT.

Approval was based on the pivotal Phase 3 CodeBreaK 300 study.

BioMed X, an independent biomedical research institute based in Germany, has launched a new collaboration with Daiichi Sankyo Co., Ltd.—marking the start of a new initiative to explore innovative ...

Lyndra Therapeutics, a clinical-stage biopharmaceutical company, has entered a strategic collaboration with Thermo Fisher ...

Emmes Group, a specialty tech and AI-enabled global contract research organization (CRO), has appointed Germaine Gross as ...

Caris Life Sciences, a provider of molecular profiling and artificial intelligence (AI)-driven solutions for cancer treatment ...

Ravensburg, January 14, 2025: Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has ...

Touchlight’s facility in Hampton, UK has received GMP certification, making the CDMO the first synthetic DNA manufacturer ...